Threshold drug moves forward on cancer trial but stock falls

Good news from a late-stage cancer study from Threshold Pharmaceuticals Inc. isn't translating into a boon for its stock...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.